East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Rituximab
MabThera
Routinely available
SMC (975/14)
01/10/2014

Indication

For non-Hodgkin' s lymphoma (NHL) in adults: - previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy; - maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy; - treatment of patients with CD20...

For non-Hodgkin' s lymphoma (NHL) in adults: - previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy; - maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy; - treatment of patients with CD20 positive diffuse large B cell - non-Hodgkin's lymphoma in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy.

Therapeutic Area

Malignant disease and immunosuppression

Status Description

Routinely available

Formulation

1400mg solution for subcutaneous injection

Comments

October 2014 - Included on the Additional List, Specialist Use only, for the indication in question.

Link to Advice

975/14

Advice Published

07/07/2014

SMC Submission Type

Full

SMC Status

Restricted